Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TSHA | Taysha Gene Therapies, Inc. | Chief Executive Officer, Director | $4.44M | Jan 2, 2024 | ||
VTR | Ventas, Inc. | Director | $1.02M | May 14, 2024 | ||
DNAB | Social Capital Suvretta Holdings Corp. II | Director | Sep 24, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|